Patrick Trucchio
Stock Analyst at HC Wainwright & Co.
(4.15)
# 471
Out of 5,113 analysts
387
Total ratings
44.44%
Success rate
16.46%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Patrick Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASMB Assembly Biosciences | Assumes: Buy | $50 | $35.26 | +41.80% | 1 | Aug 18, 2025 | |
| ALT Altimmune | Reiterates: Buy | $12 | $3.90 | +207.69% | 19 | Aug 13, 2025 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $500 → $570 | $400.23 | +42.42% | 27 | Aug 7, 2025 | |
| CMPS COMPASS Pathways | Maintains: Buy | $45 → $40 | $6.37 | +527.94% | 17 | Aug 4, 2025 | |
| ATAI Atai Beckley | Maintains: Buy | $10 → $15 | $3.96 | +278.79% | 20 | Jul 30, 2025 | |
| ANRO Alto Neuroscience | Reiterates: Buy | $10 | $19.98 | -49.95% | 2 | Jun 26, 2025 | |
| IVVD Invivyd | Reiterates: Buy | $5 | $2.30 | +117.39% | 19 | Jun 26, 2025 | |
| SGMO Sangamo Therapeutics | Reiterates: Buy | $10 | $0.45 | +2,140.14% | 26 | Jun 24, 2025 | |
| SLN Silence Therapeutics | Reiterates: Buy | $75 | $6.35 | +1,081.10% | 24 | Jun 13, 2025 | |
| IMCR Immunocore Holdings | Reiterates: Buy | $100 | $36.01 | +177.70% | 21 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $23.99 | +191.79% | 15 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.01 | +395.05% | 18 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $4.49 | +1,236.30% | 18 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $68.16 | +17.37% | 23 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $12.96 | +208.64% | 15 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $4.00 | +650.00% | 10 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $37.81 | +85.14% | 6 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $26.57 | +201.09% | 8 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $10 | $2.15 | +365.12% | 19 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $3.44 | +190.70% | 16 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $12.70 | +333.07% | 18 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $110 | $5.76 | +1,809.72% | 23 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $84.00 | +1.19% | 2 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $190 → $150 | $7.18 | +1,989.14% | 17 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $170 → $68 | $11.50 | +491.30% | 2 | Sep 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $260 → $340 | $147.08 | +131.17% | 1 | Aug 18, 2021 |
Assembly Biosciences
Aug 18, 2025
Assumes: Buy
Price Target: $50
Current: $35.26
Upside: +41.80%
Altimmune
Aug 13, 2025
Reiterates: Buy
Price Target: $12
Current: $3.90
Upside: +207.69%
Alnylam Pharmaceuticals
Aug 7, 2025
Maintains: Buy
Price Target: $500 → $570
Current: $400.23
Upside: +42.42%
COMPASS Pathways
Aug 4, 2025
Maintains: Buy
Price Target: $45 → $40
Current: $6.37
Upside: +527.94%
Atai Beckley
Jul 30, 2025
Maintains: Buy
Price Target: $10 → $15
Current: $3.96
Upside: +278.79%
Alto Neuroscience
Jun 26, 2025
Reiterates: Buy
Price Target: $10
Current: $19.98
Upside: -49.95%
Invivyd
Jun 26, 2025
Reiterates: Buy
Price Target: $5
Current: $2.30
Upside: +117.39%
Sangamo Therapeutics
Jun 24, 2025
Reiterates: Buy
Price Target: $10
Current: $0.45
Upside: +2,140.14%
Silence Therapeutics
Jun 13, 2025
Reiterates: Buy
Price Target: $75
Current: $6.35
Upside: +1,081.10%
Immunocore Holdings
Jun 2, 2025
Reiterates: Buy
Price Target: $100
Current: $36.01
Upside: +177.70%
May 29, 2025
Reiterates: Buy
Price Target: $70
Current: $23.99
Upside: +191.79%
May 21, 2025
Reiterates: Buy
Price Target: $5
Current: $1.01
Upside: +395.05%
May 21, 2025
Reiterates: Buy
Price Target: $60
Current: $4.49
Upside: +1,236.30%
May 20, 2025
Reiterates: Buy
Price Target: $80
Current: $68.16
Upside: +17.37%
May 9, 2025
Reiterates: Buy
Price Target: $40
Current: $12.96
Upside: +208.64%
Apr 8, 2025
Reiterates: Buy
Price Target: $30
Current: $4.00
Upside: +650.00%
Apr 8, 2025
Reiterates: Buy
Price Target: $70
Current: $37.81
Upside: +85.14%
Apr 7, 2025
Reiterates: Buy
Price Target: $80
Current: $26.57
Upside: +201.09%
Apr 1, 2025
Maintains: Buy
Price Target: $25 → $10
Current: $2.15
Upside: +365.12%
Mar 18, 2025
Reiterates: Buy
Price Target: $10
Current: $3.44
Upside: +190.70%
Mar 7, 2025
Reiterates: Buy
Price Target: $55
Current: $12.70
Upside: +333.07%
Feb 28, 2025
Reiterates: Buy
Price Target: $110
Current: $5.76
Upside: +1,809.72%
Feb 19, 2025
Reiterates: Buy
Price Target: $85
Current: $84.00
Upside: +1.19%
Feb 13, 2025
Maintains: Buy
Price Target: $190 → $150
Current: $7.18
Upside: +1,989.14%
Sep 23, 2022
Maintains: Buy
Price Target: $170 → $68
Current: $11.50
Upside: +491.30%
Aug 18, 2021
Maintains: Outperform
Price Target: $260 → $340
Current: $147.08
Upside: +131.17%